Edit
Hospira
http://www.hospira.com/Last activity: 12.11.2024
Active - Reference to Pfizer Hospital US
Location: United States, New York
Employees: 10001+
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | NovaQuest ... | novaquest.... |
Mentions in press and media 19
| Date | Title | Description |
| 12.11.2024 | Exclusive: Pfizer explores sale of hospital drugs unit, sources say | Sustainable Finance & ReportingMergers & Acquisitions Shareholder Activism Corporate Structure Health Exclusive: Pfizer explores sale of hospital drugs unit, sources say By Anirban SenNovember 12, 20243:31 PM UTCUpdated ago Text Sma... |
| 01.12.2015 | Drug Pump Maker Denies Security Patch to Researcher Who Found Vulnerabilities | Hospira, a medical device manufacturer with a history of Food and Drug Administration warnings about the security of its drug pumps, has refused to issue a software update containing a security patch for its LifeCare PCA5 Infusion Pump Syst... |
| 09.04.2014 | Emerging medtech margins: Don’t think price, think COGS | By Tim Kofol, S2N Health Fact: the prices of medical devices, whether innovative or commodity, are under significant pressure from all corners and in all parts of the globe, and will continue to be for the foreseeable future. Fact: whether ... |
| 15.08.2013 | Recall: FDA sounds the alarm on Hospira blood kits after 1 patient dies | The FDA issued a Class I recall on blood kits made by Hospira (NYSE:HSP) after the medical device company reported that at least 1 patient’s death was partially due to a delay in treatment caused by a punctured blood bag. The company warned... |
| 29.04.2013 | Recall: FDA issues Class 1 recall for Hospira’s GemStar infusion system battery | A Class 1 recall has been issued by the FDA for batteries in the GemStar infusion system made by medical device company Hospira (NYSE:HSP). The federal watchdog agency issued the alert for all models of the GemStar infusion pump, intended f... |
| 13.09.2012 | Catheter infection startup thinks it’s found an overlooked source of contamination in IV tube connector | “Adoption was a little bit slow,” Farrar admitted of the company’s flagship device, DualCap, which has been on the market for several months. “We have several competitors that beat us to market.” Conceptualized by two nurses and U.S. Food a... |
| 10.05.2012 | Propofol drug shortages: The economic problem of a generic injectable | Three years ago, propofol was available from three companies. Besides Hospira, Teva Pharmaceutical and APP Pharmaceticals also made the sterile injectable drug. But certain lots of Teva propofol were subject to a 2009 recall due to possible... |
| 29.12.2011 | Hospira class actions claim company failed to disclose problems at N.C. plant | Hospira now faces at least two class action lawsuits filed in U.S. District Court for the Northern District of Illinois. One has been filed by Los Angeles firm Glancy Binkow & Goldberg. Another was filed by New York firm Harwood Feffer.... |
| 08.12.2011 | Novartis gets FDA warning letter for N.C., Colorado and Quebec plants | Novartis, headquartered in Basel, Switzerland, has had at least three years notice for some of the problems. Many of the violations were first raised in a 2008 warning letter regarding the company’s Wilson, North Carolina plant. In the new ... |
| 28.11.2011 | New report: The nation’s top 10 life sciences clusters | Rounding out the top 10 were Philadelphia, San Diego, Minneapolis, Raleigh-Durham and Seattle. Jones Lang LaSalle chose six measures as its criteria: high-tech research and hospital/medical employment, science and engineering graduate stude... |
Show more